Prudential Financial’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $28.4M | Sell |
354,327
-33,550
| -9% | -$2.77M | 0.03% | 324 |
|
|
2025
Q4 | $33.1M | Buy |
387,877
+28,655
| +8% | +$2.35M | 0.04% | 294 |
|
|
2025
Q3 | $27.9M | Sell |
359,222
-115,081
| -24% | -$8.99M | 0.03% | 353 |
|
|
2025
Q2 | $37.1M | Sell |
474,303
-189,137
| -29% | -$14.1M | 0.05% | 285 |
|
|
2025
Q1 | $48.1M | Buy |
663,440
+230,980
| +53% | +$16.5M | 0.07% | 218 |
|
|
2024
Q4 | $32M | Buy |
432,460
+60,171
| +16% | +$4.21M | 0.04% | 283 |
|
|
2024
Q3 | $24.6M | Sell |
372,289
-4,161
| -1% | -$302K | 0.03% | 387 |
|
|
2024
Q2 | $34.8M | Sell |
376,450
-50,379
| -12% | -$4.46M | 0.05% | 299 |
|
|
2024
Q1 | $40.8M | Sell |
426,829
-33,756
| -7% | -$2.84M | 0.06% | 280 |
|
|
2023
Q4 | $34.2M | Sell |
460,585
-97,632
| -17% | -$6.79M | 0.05% | 303 |
|
|
2023
Q3 | $38.7M | Sell |
558,217
-331,137
| -37% | -$26.6M | 0.06% | 274 |
|
|
2023
Q2 | $83.9M | Buy |
889,354
+161,919
| +22% | +$14.1M | 0.12% | 159 |
|
|
2023
Q1 | $68M | Buy |
727,435
+60,567
| +9% | +$4.76M | 0.11% | 184 |
|
|
2022
Q4 | $49.8M | Sell |
666,868
-923,207
| -58% | -$71.2M | 0.08% | 233 |
|
|
2022
Q3 | $131M | Sell |
1,590,075
-34,906
| -2% | -$3.36M | 0.22% | 98 |
|
|
2022
Q2 | $155M | Buy |
1,624,981
+346,194
| +27% | +$35.8M | 0.25% | 84 |
|
|
2022
Q1 | $151M | Buy |
1,278,787
+76,131
| +6% | +$8.54M | 0.2% | 102 |
|
|
2021
Q4 | $144M | Buy |
1,202,656
+125,454
| +12% | +$14.6M | 0.18% | 124 |
|
|
2021
Q3 | $122M | Buy |
1,077,202
+529,410
| +97% | +$60.4M | 0.17% | 129 |
|
|
2021
Q2 | $56.7M | Sell |
547,792
-116,360
| -18% | -$11M | 0.08% | 245 |
|
|
2021
Q1 | $55.5M | Buy |
664,152
+64,356
| +11% | +$5.44M | 0.08% | 223 |
|
|
2020
Q4 | $54.7M | Sell |
599,796
-406,217
| -40% | -$33.7M | 0.09% | 205 |
|
|
2020
Q3 | $80.3M | Sell |
1,006,013
-1,285,720
| -56% | -$100M | 0.15% | 133 |
|
|
2020
Q2 | $158M | Buy |
2,291,733
+153,627
| +7% | +$10.9M | 0.3% | 70 |
|
|
2020
Q1 | $134M | Sell |
2,138,106
-536,409
| -20% | -$38.7M | 0.3% | 73 |
|
|
2019
Q4 | $208M | Buy |
2,674,515
+684,420
| +34% | +$53.4M | 0.31% | 68 |
|
|
2019
Q3 | $146M | Buy |
1,990,095
+1,352,907
| +212% | +$95M | 0.23% | 91 |
|
|
2019
Q2 | $39.2M | Buy |
637,188
+38,790
| +6% | +$2.35M | 0.06% | 329 |
|
|
2019
Q1 | $38.2M | Sell |
598,398
-200,067
| -25% | -$11.4M | 0.06% | 330 |
|
|
2018
Q4 | $40.8M | Sell |
798,465
-361,833
| -31% | -$18.3M | 0.07% | 283 |
|
|
2018
Q3 | $67.3M | Sell |
1,160,298
-162,372
| -12% | -$7.94M | 0.1% | 195 |
|
|
2018
Q2 | $64.2M | Sell |
1,322,670
-236,382
| -15% | -$11M | 0.1% | 228 |
|
|
2018
Q1 | $72.5M | Buy |
1,559,052
+310,224
| +25% | +$13.5M | 0.11% | 186 |
|
|
2017
Q4 | $47.1M | Buy |
1,248,828
+55,350
| +5% | +$2.03M | 0.06% | 341 |
|
|
2017
Q3 | $43.5M | Sell |
1,193,478
-40,770
| -3% | -$1.55M | 0.06% | 353 |
|
|
2017
Q2 | $48.6M | Sell |
1,234,248
-77,853
| -6% | -$2.84M | 0.07% | 307 |
|
|
2017
Q1 | $41.1M | Buy |
1,312,101
+238,560
| +22% | +$7.47M | 0.06% | 335 |
|
|
2016
Q4 | $33.5M | Sell |
1,073,541
-533,700
| -33% | -$17.3M | 0.05% | 382 |
|
|
2016
Q3 | $64.6M | Buy |
1,607,241
+181,323
| +13% | +$6.83M | 0.11% | 202 |
|
|
2016
Q2 | $47.4M | Buy |
1,425,918
+88,770
| +7% | +$3.04M | 0.08% | 255 |
|
|
2016
Q1 | $39.3M | Sell |
1,337,148
-218,040
| -14% | -$6.02M | 0.07% | 285 |
|
|
2015
Q4 | $40.9M | Sell |
1,555,188
-1,286,040
| -45% | -$33.4M | 0.07% | 275 |
|
|
2015
Q3 | $67.3M | Buy |
2,841,228
+187,560
| +7% | +$4.53M | 0.13% | 163 |
|
|
2015
Q2 | $63M | Buy |
2,653,668
+1,005,900
| +61% | +$22.7M | 0.11% | 184 |
|
|
2015
Q1 | $39.1M | Buy |
1,647,768
+780,180
| +90% | +$17.5M | 0.07% | 317 |
|
|
2014
Q4 | $18.4M | Buy |
867,588
+29,640
| +4% | +$595K | 0.03% | 517 |
|
|
2014
Q3 | $14.3M | Sell |
837,948
-90,528
| -10% | -$1.43M | 0.03% | 575 |
|
|
2014
Q2 | $13.3M | Buy |
928,476
+20,688
| +2% | +$280K | 0.02% | 632 |
|
|
2014
Q1 | $11.2M | Sell |
907,788
-34,200
| -4% | -$395K | 0.02% | 676 |
|
|
2013
Q4 | $10.3M | Sell |
941,988
-50,400
| -5% | -$568K | 0.02% | 686 |
|
|
2013
Q3 | $11.5M | Sell |
992,388
-72,948
| -7% | -$853K | 0.02% | 623 |
|
|
2013
Q2 | $11.9M | Buy |
+1,065,336
| New | +$12.6M | 0.03% | 590 |
|
Other funds holding EW
VCM
VPM
Prudential Financial's EW Position: Q1 2026 in Review
Prudential Financial reduced its Edwards Lifesciences (EW) stake by 8.6% in Q1 2026, selling an estimated $2.77M and leaving 354,327 shares worth $28.4M. The position accounts for 0.03% of the portfolio, ranked #324.
Prudential Financial first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $208M in Q4 2019. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Prudential Financial held 354,327 shares of Edwards Lifesciences worth $28.4M as of Q1 2026.
- Prudential Financial sold 33,550 Edwards Lifesciences shares in Q1 2026, an estimated $2.77M.
- Edwards Lifesciences made up 0.03% of Prudential Financial's portfolio in Q1 2026, its #324 holding.
- Prudential Financial first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
- Prudential Financial's Edwards Lifesciences position peaked at $208M in Q4 2019.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.